Introduction
MAP kinase cascades are universal signal transduction modules that are evolutionarily conserved and used in a wide variety of biological response mechanisms. In vertebrates, at least three such pathways have been identified, which activate different MAP kinase classes, known as ERK, JNK and p38 (Treisman, 1996; Robinson and Cobb, 1997) . Even though these signalling systems are built from evolutionarily related protein kinases, they convey distinct biological responses. Whereas ERK signalling is generally involved in the control of cell proliferation and differentiation, JNK and p38 signal transduction pathways mediate responses to various forms of cellular stress, such as damage repair mechanisms, cell growth 4404 © Oxford University Press arrest and cell death. The biological effects of MAP kinase signalling are executed by downstream phosphorylation substrates, most notably a number of signal-responsive transcription factors. A conceptual complication arose when it became evident that several of the MAP kinaseregulated transcription factors such as Elk1 and ATF-2 can serve as substrates for more than one MAP kinase and thus participate in different biological responses (Gupta et al., 1995; Livingstone et al., 1995; Van Dam et al., 1995; Whitmarsh et al., 1995 Whitmarsh et al., , 1997 Price et al., 1996) . This raised the question of how the specificity of signal response is maintained, i.e. how distinct biological responses are mounted after kinases with similar or overlapping substrate specificity are activated.
The transcription factor c-Jun provides a useful model to study the complexity and specificity of signalling. c-Jun is an inducible transcription factor which directs changes of gene expression in response to multiple extracellular stimuli (Angel and Karin, 1991; Karin et al., 1997) . Transcription of c-jun mRNA rises after exposure of cells to a number of treatments including exposure to mitogens and various forms of stress. In addition to this transcriptional mode of regulation, c-Jun activity can also be modulated directly at the protein level. Most notable in this regard are regulatory phosphorylations occurring on Ser63 and Ser73, and Thr91 and/or Thr93 within the trans-activation domain (Pulverer et al., 1991; Smeal et al., 1992; Papavassiliou et al., 1995) . Phosphorylation of these residues results in the stabilization of c-Jun, as well as enhanced trans-activation and DNA-binding activity (Devary et al., 1992; Radler-Pohl et al., 1993; Papavassiliou et al., 1995; Musti et al., 1997) . In certain cells, these phosphorylation events have been attributed to the MAP kinases ERK1 and ERK2 Pulverer et al., 1991 Pulverer et al., , 1993 Smeal et al., 1991) . ERKs are regulated by growth factors, neurotrophins and phorbol esters. The signal for ERK activation is relayed from the cell surface to the nucleus through a wellcharacterized signal transduction pathway involving activation of the small GTP-binding protein Ras, and a kinase cascade comprised of Raf, MEK and ERKs (Marshall, 1995; Treisman, 1996) . c-Jun is also a substrate for a related group of MAPKs, called stress-activated protein kinases (SAPKs), or Jun Nterminal kinases (JNKs) (Kyriakis and Avruch, 1996; Treisman, 1996) . Exposure of cells to certain cytokines, protein synthesis inhibitors, or various forms of stress, triggers a kinase cascade leading to the activation of JNK, which can bind directly to and phosphorylate c-Jun (Hibi et al., 1993; Dérijard et al., 1994; Kyriakis et al., 1994; Sánchez et al., 1994) . Analogous to the ERK cascade, the JNK pathway involves the sequential activation of three kinases called MEKK, SEK and JNK, respectively (Kyriakis and Avruch, 1996; Robinson and Cobb, 1997) . With the discovery of JNKs, it became apparent that these enzymes phosphorylate c-Jun more efficiently than ERKs in vitro (Dérijard et al., 1994; Minden et al., 1994a,b) . Thus, the role of ERKs in the regulation of c-Jun activity has come into question.
The diversity of signals and signalling pathways that are directed toward c-Jun is also reflected in the biological responses, in which the transcription factors have been implicated. It was thought earlier that the main function of c-Jun is to transmit proliferative signals in a cell (Schütte et al., 1989; Bos et al., 1990; Castellazzi et al., 1991; Lloyd et al., 1991; Johnson et al., 1993) . Paradoxically, it has also been reported that c-Jun is involved in certain types of apoptotic cell death. For example, dominant-negative mutants of c-Jun, or antibodies against c-Jun were shown to protect neuronal cells from apoptosis induced by nerve growth factor (NGF) withdrawal, a treatment which activates the JNK and p38 kinase cascades (Estus et al., 1994; Ham et al., 1995; Xia et al., 1995) . Finally, Jun signalling can positively or negatively regulate differentiation in a number of systems (Bengal et al., 1992; Treier et al., 1995; Hou et al., 1997; Kockel et al., 1997; Riesgo-Escovar and Hafen, 1997) . The exact molecular role that c-Jun plays in these different situations awaits clarification.
To examine the role of c-Jun as a target for ERK and JNK signalling, we performed studies in PC12 cells, a well-established experimental system in which the choice between a range of different biological signal responses, proliferation, neuronal differentiation and cell death, can be studied in tissue culture. NGF treatment causes differen-4405 tiation into a sympathetic neuron-like cell. This coincides with the cessation of cell proliferation, neurite outgrowth and expression of immediate early genes, including c-jun and c-fos, as well as late response genes believed to function as determinants of neuronal differentiation (Sheng and Greenberg, 1990) . The NGF response in PC12 cells requires activation of ERKs, since blocking the kinase cascade either by a specific inhibitor or by expression of dominant interfering mutants or antibodies against Ras or MEK1 inhibits the differentiation (Kremer et al., 1991; Thomas et al., 1992; Cowley et al., 1994; Pang et al., 1995) . Conversely, constitutive activation of the ERKs by activated Raf, Ras or MEK1 induces differentiation (Bar-Sagi and Feramisco, 1985; Noda et al., 1985; Wood et al., 1993; Cowley et al., 1994) . Here, we used the PC12 cell system to investigate if and how activation of c-Jun by phosphorylation contributes to neuronal differentiation of PC12 cells, and how the differential response to JNK and ERK activation might be mediated.
Results

Phosphorylated c-Jun induces neurite outgrowth in PC12 cells
To study the functional role of c-Jun phosphorylation in PC12 cell differentiation, plasmids encoding various c-Jun derivatives in which previously identified MAPK substrate residues had been modified, were introduced into PC12 cells by microinjection. The expression of the HA-epitopetagged c-Jun derivatives in recipient cells was monitored by immunostaining with anti-HA antibodies ( Figure 1A) . In c-Jun Asp , potential MAPK phosphorylation sites, including Ser63 and Ser73, and Thr91 and Thr93, have been replaced by phosphate-mimicking aspartic acid residues . This 'gain of function' mutant acts like the active phosphoprotein in several assays (Papavassiliou et al., 1995; Treier et al., 1995; Musti et al., 1997) . Expression of c-Jun Asp caused the development of long neurites in Ͼ50% of microinjected PC12 cells ( Figure  1B) . If the concentration of the Jun Asp expression vector was titrated down from the standard concentration of 50 μg/ml in the injected solution to 2 μg/ml, significant neurite outgrowth was still detected (data not shown), indicating that moderate overexpression was sufficient to elicit the described effects. In control experiments, c-Jun Ala (a mutant which cannot be phosphorylated by MAPKs) and c-Jun wt caused flattening of the cells, increased cell diameter and only moderate neurite formation ( Figure  1B ). The cells developed fewer and notably shorter neurites as compared with those injected with c-Jun Asp ( Figure  1C ). Control cells injected with an expression vector for nuclear β-galactosidase were not induced to differentiate. We conclude that phosphorylation of c-Jun plays an important role in directing PC12 cells towards a neuronal differentiation pathway.
c-Jun is a downstream target of the ERK pathway in PC12 cells
Since the results shown in Figure 1 imply that activation of c-Jun by phosphorylation, as mimicked by c-Jun Asp expression, is sufficient to cause PC12 cell differentiation, we next examined whether differentiation in response to NGF involves the same mechanism. Thus, the phosphorylation state of c-Jun upon NGF treatment was determined. PC12 cells expressing c-Jun wt were treated with NGF, and immunostained with an antibody (anti-c-Jun Ser 63 P) that specifically recognizes the Ser63-phosphorylated form of c-Jun but not c-Jun that is unphosphorylated at this site. Figure 2A shows that Ser63-phosphorylated c-Jun was hardly detectable in unstimulated cells. However, NGF treatment induced prominent c-Jun phosphorylation. Thus, NGF induces phosphorylation of c-Jun in PC12 cells which, according to the data shown in Figure 1 , would be sufficient to initiate neuronal differentiation.
We next investigated the pathway through which the NGF signal is transmitted to the PC12 cell nucleus to induce c-Jun phosphorylation. It has previously been shown that NGF stimulates a signal transduction pathway that culminates in the activation of ERKs. Furthermore, PC12 cells differentiate in response to expression of activated components of this pathway, such as Ras, Raf and MEK1 (Bar-Sagi and Feramisco, 1985; Noda et al., 1985; Wood et al., 1993; Cowley et al., 1994) . Hence, we first tested whether MEK1, a MAPK kinase specific for ERKs, could be a mediator between NGF and c-Jun phosphorylation. When c-Jun was co-expressed with a constitutively activated form of MEK1 (MEK EE ; see Materials and methods) and ERK2, intense nuclear immunostaining was detected with the anti-c-Jun Ser 63 P antibody (Figure 2A ). Under our experimental conditions, expression of MEK EE or ERK2 alone did not result in strong phosphorylation (Figure 2B and C; data not shown), indicating that ERK protein concentration is a limiting factor for c-Jun phosphorylation in the cells. Prominent c-Jun phosphorylation was also detected in cells in which c-Jun was co-expressed with an activated JNK pathway component, such as the constitutively active MEKK1 (ΔMEKK), comprised of a 672-residue C-terminal fragment of the molecule (Whitmarsh et al., 1995) (Figure  2A ), or activated SEK plus JNK (data not shown). To corroborate these findings, we performed immunoblotting experiments with extracts from transiently transfected PC12 cells using phospho-specific antibodies or antibodies that are not sensitive to the phosphorylation state of c-Jun. In agreement with the immunostaining results shown in Figure 2A , we find that co-expression with MEK EE and ERK2 results in significant phosphorylation of c-Jun on Ser63 and Ser73. Qualitatively similar results were obtained when the same experiment was performed in NIH 3T3 cells, and after co-transfection with ΔMEKK. Taken together, these results indicate that, in both PC12 and NIH 3T3 cells, c-Jun can be phosphorylated on Ser63 and Ser73 in an ERK-or a JNK-dependent manner. To monitor directly the specificity of MAPK activation under our assay conditions we performed immunocomplex kinase assays ( Figure 2C ). This experiment shows that, as expected, MEK EE stimulated the kinase activity of HAtagged ERK2 measured on MBP as a substrate. Importantly, no significant ERK activation was observed after co-expression with ΔMEKK, indicating that under our experimental conditions there is no cross-talk between the JNK and ERK signalling pathway. This finding further supports our conclusion that c-Jun is a target to ERK phosphorylation in PC12 cells. In contrast, ΔMEKK specifically activated JNK and had no effect on ERK activity. Like others (Minden et al., 1994a,b) we observed no phosphorylation of c-Jun by ERK in vitro. This negative result may be explained by a requirement for further factors in the cell that facilitate the phosphorylation of c-Jun by ERK.
To gain further insight into the relationship between ERK, JNK and c-Jun activation in PC12 cell differentiation, we analysed the phosphorylation state and hence the activity of these proteins over a time course following NGF addition. The top panel of Figure 3A shows that both the expression levels and the phosphorylation of endogenous c-Jun protein is increased after NGF treatment of PC12 cells. The expression of c-Jun directed from a transfected CMV vector is not stimulated by NGF ( Figure  3A , bottom panel) and thus permits assessment of NGFdependent c-Jun phosphorylation over time at constant protein levels. This experiment reveals a kinase activity present in PC12 cells for hours after NGF induction that can specifically phosphorylate c-Jun. ERKs are good candidates for such an activity, as the strong and sustained activation of ERK1 and ERK2 ( Figure 3B ) correlates well with the persistence of phosphorylated forms of c-Jun ( Figure 3A) . In contrast, we observed only a weak and transient JNK1 activation after 15 min of NGF treatment, whereas JNK2 activity was not increased or even slightly reduced ( Figure 3C ). Consistently, when we measured JNK activation by immunocomplex kinase assay, we found that the basal levels of JNK activity were reduced upon exposure of cells to NGF ( Figure 3C, bottom panel) . Thus, while a contribution of JNK to c-Jun phosphorylation cannot be completely excluded, the kinetics and amplitude of ERK activity is more compatible with a major function of the latter class of MAPKs in the phosphorylation of c-Jun upon NGF treatment.
If c-Jun is an essential downstream component of the MEK1/ERK-mediated differentiation in PC12 cells, a dominant-negative form of c-Jun would be expected to interfere with this process. Conversely, wild-type c-Jun might be anticipated to enhance neurite outgrowth. Figure 4 shows that co-expression of c-Jun wt with MEK EE did not markedly increase the number of cells forming neurites, yet the neurites were longer, as compared with cells expressing MEK EE alone. Similar results were obtained after co-expressing MEK EE and ERK2 (data not shown). In contrast, co-expression of c-Jun bZIP , a truncated, dominant-negative form of Jun, caused marked inhibition of MEK1 and ERK2-induced neurite outgrowth. Expression of c-Jun bZIP alone did not result in any cellular responses ( Figure 4B ). These results therefore provide evidence that the MAPK/ERK pathway can trigger c-Jun phosphorylation, and that this event is critical for PC12 cell differentiation in response to NGF.
JNK can induce neuronal differentiation only if c-Jun is co-expressed
Next, we asked whether JNK, which can also phosphorylate the Ser63 and Ser73 residues of c-Jun, may elicit PC12 cell differentiation when activated. In the JNK signalling pathway, MEKK1 phosphorylates and activates SEK1, also called MKK4, which in turn activates JNK by phosphorylating its regulatory Tyr and Thr residues (Lange-Carter et al., 1993; Dérijard et al., 1994; Kyriakis et al., 1994; Sánchez et al., 1994; Yan et al., 1994; Lin et al., 1995) . Two components of the JNK pathway, ΔMEKK and partially active SEK1 (SEK ED ), in which the regulatory phosphorylation sites have been substituted by glutamic and aspartic acid residues (J.Woodgett, personal communication) were used in the experiments. Immunoblot analysis of transiently transfected NIH 3T3 cells ( Figure 5A ) indicated that SEK ED could induce phosphorylation of c-Jun wt in vivo, albeit to a lesser extent than MEK EE . Phosphorylation of c-Jun was strongest when c-Jun was co-expressed with ΔMEKK. The same assay was also performed using c-Jun Ala as a substrate for these kinases. c-Jun Ala was not recognized by anti-c-Jun Ser63 or Ser73 phosphate antibodies, verifying the specificity of these antibodies.
The ability of the activated components of the JNK pathway to elicit PC12 cell differentiation responses was examined using the microinjection assay ( Figure 5B ). In contrast to MEK EE (Figure 4) , neither SEK ED nor ΔMEKK induced neurite outgrowth when expressed in PC12 cells, which further indicates that activation of JNK pathway is not sufficient to induce PC12 cell differentiation. However, consistent with previously published results (Xia et al., 1995) , we found that ΔMEKK-expressing cells underwent apoptosis. PC12 cells expressing SEK ED displayed neither differentiation nor apoptosis. If, however, SEK ED or ΔMEKK were expressed along with c-Jun wt , marked neurite outgrowth ensued ( Figure 5B and C) . The fraction of differentiating cells, as well as the average length of the appearing neurites, was significantly increased as compared with cells that had received c-Jun wt alone ( Figure  5C and D) . Interestingly, the apoptotic effect of ΔMEKK was suppressed when c-Jun was co-expressed. The basis for this is unclear and subject to further investigation. The cooperation between JNK and c-Jun in the induction of neurite outgrowth suggests that c-Jun phosphorylation is sufficient to induce PC12 cell differentiation, regardless of whether it is mediated by MEK-induced ERK activity or through activation of JNK.
ERK-but not JNK-activation induces c-Jun expression in PC12 cells
An attractive hypothesis to explain the above results poses that PC12 cell differentiation requires two events, namely the induction of c-Jun synthesis and c-Jun phosphorylation. Whereas both ERK and JNK can catalyse phosphorylation of the relevant sites in c-Jun, only the former can stimulate c-Jun expression in PC12 cells efficiently (Figure 7) . According to this model, JNK activation would thus not be sufficient to stimulate differentiation, unless c-Jun is provided in trans. To test this idea, we investigated whether endogenous c-Jun expression can be induced by specifically activating either the ERK or the JNK pathway. MEK EE , SEK ED or ΔMEKK were expressed in PC12 cells, and endogenous c-Jun expression was examined by immunostaining ( Figure 6 ). Interestingly, expression of MEK EE caused a significant increase in c-Jun expression similar to the one seen in NGF-or TPA-treated PC12 cells ( Figure 6 , right panel), In contrast, ΔMEKK, which effectively activates JNK, resulted in only marginal c-Jun induction. When PC12 cells were injected with expression plasmid for SEK ED , c-Jun expression was not detectably induced. Taken together, these results establish a biologically relevant difference between the ERK and the JNKsignalling in the regulation of c-Jun activation.
Discussion
Several lines of evidence presented here suggest that c-Jun can act as a substrate for ERK phosphorylation in at least two different cell types, and that in the NGF response, ERK-mediated activation of c-Jun directs PC12 cells towards neuronal differentiation. First, analogous to activated components of the Ras/MAPK pathway such as Ras, Raf or MEK1 (Bar-Sagi and Feramisco, 1985; Noda et al., 1985; Wood et al., 1993; Cowley et al., 1994) , expression of c-Jun Asp in PC12 cells induced marked neurite outgrowth. Secondly, NGF treatment of PC12 cells induced sustained activation of ERKs and phosphorylation of c-Jun. A transient small increase in JNK1 activity after NGF exposure does not match the kinetics of c-Jun phosphorylation. Thirdly, expression of constitutively active MEK and ERK, which has been shown previously to lead to PC12 cell differentiation (Cowley et al., 1994) , resulted in prominent c-Jun expression and phosphorylation on Ser63 and Ser73, but not JNK activation. Fourthly, expression of c-Jun potentiated differentiation of PC12 cells induced by MEK1, whereas dominant-negative mutants of c-Jun inhibited it.
Thus, while ERKs are less effective kinases of c-Jun in vitro, as compared with JNKs, phosphorylation of c-Jun by ERKs appears to mediate signal responses in vivo, at least during PC12 cell differentiation. This is consistent with our recent findings in Drosophila, which indicate that Jun can act as an effector of both JNK and ERK pathways during development of this organism (Peverali et al., 1996; Kockel et al., 1997) . Nevertheless, JNKs can phosphorylate c-Jun more efficiently than ERKs on the sites which, according to our mutant analysis, are critical for PC12 cell differentiation. Considering this-and our finding that phosphorylation of c-Jun on these sites is sufficient to direct PC12 cells along a path of neuronal differentiation-one might predict that activation of the JNK pathway would also induce PC12 cells to differentiate. However, this is not the case. Stimulation of JNK activity either by activated forms of MEKK or SEK does not trigger neurite formation in the way that it was seen when the ERK pathway was stimulated (by MEK EE or by NGF). Instead, consistent with observations by others (Xia et al., 1995; Lassignal Johnson et al., 1996) , ΔMEKK induced apoptosis in undifferentiated PC12 cells. In this situation, c-Jun seems not to be involved, but conversely counteracts apoptosis and induces differentiation when provided in addition. Since c-Jun itself has also been implicated in apoptosis in some circumstances (Ham et al., 1995; Xia et al., 1995; Watson et al., 1998) , it seems clear that the effects of c-Jun on cellular responses depend on the cell type and the context of regulatory inputs that the cell is receiving.
Our results show that a JNK activating signal could promote neuronal differentiation in PC12 cells only when c-Jun was provided in addition. These data suggest a model in which activation of the ERK pathway in PC12 cells results in stimulation of both c-Jun synthesis and c-Jun phosphorylation, whereas the JNK pathway triggers phosphorylation only (Figure 7) . Indeed, we could show that activation of ERK pathway, but not JNK, induced prominent c-Jun expression in PC12 cells. This is consistent with recent data reporting that activation of JNK is not sufficient to activate the c-jun promoter in fibroblasts (Hazzalin et al., 1996) . Providing c-Jun exogenously, however, will turn the JNK activation into a differentiation signal. According to this model, the specificity of signal response is not based on a qualitative or quantitative difference in the way ERKs or JNKs phosphorylate Jun (e.g. in terms of kinetics or phosphorylation site preference). Phosphorylation of c-Jun by either kinase can promote PC12 cell differentiation. Based on the data presented here, we favour a combinatorial model in which a dual input on the level of transcription and phosphorylation of c-Jun is required to start a programme of neuronal differentiation in PC12 cells. There may also be situations where simultaneous activation of ERK and JNK act synergistically to elicit a response that is distinct from the response to the activation of either pathway alone.
Materials and methods
Plasmids
Plasmids for mammalian cell expression of CMV-driven epitope-tagged c-Jun wt , c-Jun Ala , c-Jun Asp and nuclear β-galactosidase have been described (Treier et al., 1994 . CMV-driven expression vector for HA-tagged dominant-negative form of c-Jun (c-Jun bZIP ) was constructed by deleting amino acids 25-181 from the sequence. Bacterial pGEX2T expression vector containing GST-c-Jun (kindly provided by F.A.Peverali) was constructed by PCR amplification of sequences containing amino acids 5-105. Constructs for mammalian pEXV expression vectors for constitutively active MEK1 and ERK2myc (Cowley et al., 1994) were provided by C.Marshall; the construct for mammalian expression of constitutively active MEKK1 (Whitmarsh et al., 1995) was provided by R.J.Davis; the construct for mammalian expression for HA-tagged JNK (Coso et al., 1995) was provided by S.Gutkind; the construct for mammalian expression for HA-tagged ERK2 was provided by C.J.Der; and the construct for mammalian expression for partially active SEK was provided by J.Woodgett.
Cell culture and transfections
Rat phaeochromocytoma PC12 cells were routinely cultured on collagencoated dishes in a humidified 7.5% CO 2 atmosphere at 37°C in DMEM, supplemented with 10% horse serum (HS) and 5% fetal calf serum (FCS). Transient transfection into PC12 cells was done with Lipofectamine according to the manufacturer's instructions (Gibco-BRL). Mouse NIH 3T3 cells were cultured in DMEM with 10% calf serum (CS). Transfection was performed using the calcium phosphate method (Graham and van der Eb, 1973) . Cells were harvested 24-36 h after transfection.
Microinjection
For microinjection, cells were seeded on laminin-coated plastic plates (20 μg/ml mouse EHS-laminin; Boehringer) to provide better adhesion and facilitate neurite outgrowth. Microinjections were performed on an automated injection system using a Zeiss inverted microscope. All plasmids were injected into the nucleus at a concentration of 50 μg/ml unless otherwise stated. 100-150 cells were injected per experiment.
Immunostaining
Cells were fixed with 2% paraformaldehyde (PFA) in phosphate-buffered saline (PBS), washed with PBS and permeabilized with 0.1% Triton X-100 in PBS on ice. Blocking with 1% bovine serum albumin (BSA) in PBS for 30 min, and incubations with primary antibodies in 1% BSA-PBS for 1 h, were done at room temperature (RT). Antibodies included a monoclonal antibody (mAb) against β-galactosidase (Promega), a mAb against HA-epitope (clone 12CA5), a mAb against mycepitope (clone 9E10), a polyclonal antibody against c-Jun (Bohmann and Tjian, 1989) , and a polyclonal antibody against phosphorylated c-Jun at position Ser63 (New England Biolabs). After several washes, bound antibodies were detected using FITC-and Texas red-conjugated secondary antibodies (Dianova) for 1 h at RT. The morphology of the cells was visualized using TRITC-labelled phalloidin (Sigma). Cells were further washed extensively with PBS, and Hoechst dye 33258 (Sigma) was included in the last wash to visualize the nuclei. Finally, the cells were mounted under a coverslip using Mowiol. Samples were examined using a Zeiss LSM410 confocal imaging system. For quantification of neurite outgrowth, the cells forming neurites longer than twice the diameter of the cell body were defined as positive.
Western blot analysis
Whole-cell extracts were prepared by lysing the cells directly in SDS sample buffer. Nuclear extracts were obtained by extracting the cells with hypotonic lysis buffer (10 mM Tris pH 7.5, 10 mM NaCl, 3 mM MgCl 2 , 0.2 mM Na 3 VO 4 , 50 μM NaF, 2 mM DTT, 0.5% NP-40), followed by solubilization of nuclei into SDS sample buffer. After sonication, protein samples (10-20 μg) were separated on SDS-polyacrylamide gels and electroblotted onto nitrocellulose filters. Immunoblotting was performed using a mAb against HA-epitope, polyclonal antibodies against phospho-c-Jun (anti-c-Jun phosphorylated on Ser63 or Ser73; New England Biolabs), polyclonal antibody against c-Jun (Bohmann and Tjian, 1989) , and polyclonal antibodies against activated phospho-ERKs and phospho-JNKs (Promega). ERK1/2 and JNK1/2 were detected by polyclonal antibodies C-14 and C-17, respectively (Santa Cruz). HRP-conjugated secondary antibodies were purchased from Dianova. The blots were developed with an enhanced chemiluminescence method (ECL, Amersham).
In vitro kinase assays
The cells were washed with PBS and solubilized in lysis buffer (25 mM HEPES-NaOH pH 7.5, 150 mM NaCl, 1% Triton X-100, 10% glycerol, 5 mM EDTA, 5 mM EGTA, 25 mM β-glycerophosphate, 0.1 mM Na 3 VO 4 ). Transiently transfected HA-tagged JNK1 was immunoprecipitated for 1 h at 4°C using monoclonal anti-HA (12CA5) antibody. Immunocomplexes were coupled to protein-A-Sepharose beads for an additional 1 h at 4°C and washed four times with dilution buffer (25 mM HEPES-NaOH pH 7.5, 5 mM EDTA, 5 mM EGTA, 25 mM β-glycerophosphate, 0.1 mM Na 3 VO 4 ), followed by one wash with kinase buffer (50 mM HEPES-NaOH pH 7.5, 10 mM MgCl 2 , 1 mM DTT, 25 mM β-glycerophosphate, 1 mM Na 3 VO 4 ). Kinase reactions were performed in the presence of 2 μCi of [γ-32 P]ATP for 20 min at 30°C using myelin basic protein (MBP) or GST-c-Jun (5-105) as a substrate. Phosphorylated proteins were analysed by SDS-polyacrylamide gel electrophoresis and autoradiography. The intensities of the radioactive signals were quantitated with a PhosphorImager (Molecular Dynamics).
